Sort
23,748 grants matching “melanoma”
ECOG Statistical Office Data Management Grant
$2,764,934Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2004 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,760,232Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2019 · CA
Consolidated Basic Cancer Research Program
$2,749,311Dario C. Altieri · Wistar Institute · P30 · FY2019 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,747,943Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2018 · CA
SWOG Biospecimen Bank
$2,742,584Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2016 · CA
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$2,741,261Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Repository Services for epidemiology studies
$2,735,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment
$2,734,241David E Fisher · Massachusetts General Hospital · P01 · FY2025 · CA
Systems Biology of Diversity in Cancer
$2,729,985Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2012 · CA
SWOG Biospecimen Bank
$2,727,061Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2018 · CA
SWOG Biospecimen Bank to Support NCI NCTN
$2,724,055Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2024 · CA
Consolidated Basic Cancer Research Program
$2,719,954Dario C. Altieri · Wistar Institute · P30 · FY2020 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,719,866Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Stem Cell-Engineered Tumor Immunity in Man
$2,716,765David Baltimore · California Institute Of Technology · P01 · FY2013 · CA
Systems Biology of Diversity in Cancer
$2,716,373Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2011 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2021 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2022 · CA
Consolidated Basic Cancer Research Program
$2,714,982Dario C. Altieri · Wistar Institute · P30 · FY2023 · CA
SPORE in Skin Cancer
$2,712,962Brigham And Women'S Hospital · P50 · FY2001 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,710,901Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2017 · CA
Immunohistochemical and genomic analysis of tumors
$2,706,048Markku Miettinen · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Systems Biology of Diversity in Cancer
$2,702,738Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2013 · CA
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,702,613James R. Heath · Institute For Systems Biology · U54 · FY2022 · CA
Allogeneic Immunotherapy for cancer and nonmalignant hematological disorders
$2,693,826Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Studies of Occupational Cancer (Pesticides)
$2,690,047Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA